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Abstract
Postcholecystectomy leaks may occur in 0.3–2.7% of pa-
tients. Bile leaks associated with laparoscopy are often more 
complex and difficult to treat than those occurring after 
open cholecystectomy. Furthermore, their incidence has re-
mained unchanged despite improvements in laparoscopic 
training and technological developments. The management 
of biliary leaks has evolved from surgery into a minimally in-
vasive endoscopic procedural approach, namely, endoscop-
ic retrograde cholangiopancreatography (ERCP), which de-
creases or eliminates the pressure gradient between the bile 
duct and the duodenum, thus creating a preferential trans-
papillary bile flow and allowing the leak to seal. For simple 
leaks, the success rate of endotherapy is remarkably high. 
However, there are more severe and complex leaks that re-
quire multiple endoscopic interventions, and clear strate-
gies for endoscopic treatment have not emerged. Therefore, 
there is still some debate regarding the optimal time point 
at which to intervene, which technique to use (sphincterot-
omy alone or in association with the placement of stents, 
whether metallic or plastic stents should be used, and, if 
plastic stents are used, whether they should be single or mul-
tiple), how long the stents should remain in place, and when 
to consider treatment failure. Here, we review the types and 
classification of postoperative biliary injuries, particularly 
leaks, as well as the evidence for endoscopic treatment of 
the latter. © 2020 Sociedade Portuguesa de Gastrenterologia
Published by S. Karger AG, Basel
Terapêutica endoscópica das fugas biliares pós-
colecistectomia
Palavras Chave
Fuga biliar · Prótese biliar · Colecistectomia · 
Colangiopancreatografia retrógrada endoscópica · CPRE ·  
Esfincterotomia
Resumo
As fugas biliares pós colecistectomia podem ocorrer em 
0,3 a 2,7% dos casos, sendo frequentemente mais com-
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plexas e difíceis de tratar quando comparamos as lesões 
provocadas pela abordagem laparoscópica versus cirur-
gia clássica. Associadamente a sua incidência não tem di-
minuído apesar da melhoria do treino em laparoscopia e 
do desenvolvimento tecnológico. O tratamento das fugas 
biliares evoluiu da cirurgia para a endoscopia permitindo, 
através da colangiopancreatografia retrógrada en-
doscópica (CPRE), executar vários procedimentos que 
têm como objetivo divergir preferencialmente o fluxo bil-
iar através da papila para o duodeno e assim reduzir ou 
eliminar a pressão no sistema biliar, eliminando o fluxo de 
bílis através da perfuração e criando condições para o seu 
encerramento. Para fugas simples a taxa de sucesso da 
CPRE é muito elevada. Contudo, existem fugas mais 
graves e complexas com necessidade de múltiplas inter-
venções, não estando definidas estratégias claras para o 
tratamento endoscópico, persistindo alguma discussão 
em relação ao timing ideal para intervir, à melhor técnica 
a utilizar (esfincterotomia isolada ou associada à coloca-
ção de próteses biliares, se estas devem ser metálicas ou 
plásticas e, neste ultimo caso, se únicas ou múltiplas), ao 
período de tempo em que devem permanecer as próteses 
biliares, e quando assumir a falência do tratamento. Neste 
artigo iremos rever os tipos e a classificação das lesões 
pós-cirúrgicas das vias biliares, nomeadamente das fugas, 
assim como a evidência para o tratamento endoscópico 
destas últimas. © 2020 Sociedade Portuguesa de Gastrenterologia 
Publicado por S. Karger AG, Basel
Introduction
Biliary leaks can be a severe surgical complication and 
are the most commonly reported postoperative biliary in-
jury, particularly after cholecystectomy [1–3].
Iatrogenic injury to the biliary tree, namely, biliary 
leaks, occurs after laparoscopic cholecystectomy in 0.3–
2.7% of patients [1, 4]. The incidence of biliary leaks in 
the era of laparoscopic approaches is significantly higher 
than for open cholecystectomy and remains relatively un-
changed since the first studies, despite well-known train-
ing and technological improvements [2, 5]. Additionally, 
bile leaks related to laparoscopy are often more complex 
and difficult to treat than those that occur after open cho-
lecystectomy [5]. There are several associated risk factors 
that increase the probability of a leak during surgery: 
(a) the existence of stones in the biliary tree after chole-
cystectomy can increase the pressure in the biliary system 
and therefore facilitate the development of a bile leak [1, 
4]; (b) in the presence of severe inflammation and fibrosis 
related to acute cholecystitis, the use of a laparoscopic 
technique makes cholecystectomy more difficult and the 
risk of incomplete gallbladder resection and injuries even 
higher [6].
The management of biliary leaks has evolved from sur-
gery into a minimally invasive procedural approach, 
namely, an endoscopic technique designated as endo-
scopic retrograde cholangiopancreatography (ERCP). 
This endoscopic technique diagnoses biliary injury and, 
when a leak exists, decreases or eliminates the pressure 
gradient between the bile duct and the duodenum, thus 
creating a preferential transpapillary bile flow and allow-
ing the leak to seal [1, 3, 6].
The outcome of leak closure can be accomplished by a 
variety of endoscopic interventions, including biliary 
stenting or nasobiliary drainage, with or without sphinc-
terotomy, or biliary sphincterotomy alone [1–4, 6]. How-
ever, biliary leaks have different grades of severity and 
complexity, and there have been reports of leaks being 
treated with multiple endoscopic procedures, or even en-
dotherapy failures for which surgery is required [1, 3, 6]. 
Due to the variety of leak complexities and available en-
dotherapy modalities, no clear strategy for endotherapy 
has emerged and, most of the time, treatment is provided 
on an individual basis. Furthermore, ERCP is associated 
with serious and not infrequent adverse events. There-
fore, the definition of the criteria, timing, and strategy for 
biliary drainage in the face of a suspected leak is para-
mount [2, 7, 8]. In this article, we review the types of post-
surgical biliary leaks and endoscopic treatment findings.
Types and Classification of Biliary Injuries
Iatrogenic injury of the biliary tree is associated with 
several types of lesions, namely, strictures (early or late 
and of minor or major severity), leaks, and transections. 
Bile duct injuries may have different causes, such as clip-
ping, burning, direct damage, and cutting, and are not 
uncommonly associated with vascular injuries, most fre-
quently to the right hepatic artery [5].
There are several classifications of iatrogenic biliary 
injuries, which differ in aim, scope, and complexity.
The first classification of biliary injuries was proposed 
by Bismuth and Majno [9] in 1982, and it mimics Bis-
muth’s classification for hilar tumors. The Bismuth clas-
sification for biliary injuries is simple, based on the loca-
tion of the injury and is very helpful after repair: type I, 
located ≥2 cm from the main hepatic confluence; type II, 
located < 2 cm from the main hepatic confluence; type III, 
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affecting the hepatic confluence, which is patent; type IV, 
involving hepatic confluence and interrupting it; and type 
V, when an aberrant right hepatic duct is injured, with or 
without injury of the CBD [5]. The strength of Bismuth’s 
classification is its simplicity and similarity to the wide-
spread classification of hilar tumors. However, it does not 
include the whole spectrum of biliary injuries.
In 1995, Strasberg et al. [10] proposed a wider classifi-
cation for iatrogenic biliary injuries (Fig. 1), which is use-
ful for classifying complex cases in which a biliary leak is 
associated with other bile duct injuries [5]. They consid-
ered 5 types of injuries, A–E, and type E is subdivided into 
5 subtypes. Type A corresponds to a bile leak from a cys-
tic duct stump or Luschka’s duct leaks, type B is an oc-
cluded right posterior sectorial duct, and type C is a bile 
leak from the divided right posterior sectorial duct. In 
type D, there is a bile leak from the main bile duct involv-
ing < 50% of its circumference. In type E1, a transected 
main bile duct with a stricture > 2 cm from the hilum is 
observed; in type E2, this stricture is located < 2 cm from 
the hilum. In type E3, there is a stricture of the hilum with 
right and left ducts in communication; in type E4, this 
stricture separates the right and the left ducts. In type E5, 
there is a stricture of the main bile duct plus a stricture of 
the right posterior sectorial duct. Types E1–E5 corre-
spond to Bismuth types I–V. Strasberg type A injuries ac-
count for up to 85% of all cases (75% are cystic duct stump 
leaks and 10% are leaks from the ducts of Luschka) [10].
One of the most popular classifications when biliary 
leaks are the predominant injury is the Amsterdam clas-
sification, which defines 4 types of injuries sustained dur-
ing laparoscopic cholecystectomy [11]: type A, leakage 
from the cystic duct or peripheral radicals; type B, major 
bile duct injury with leakage; type C, bile duct stricture 
without leakage; and type D, complete transection or ex-
cision of the common bile duct.
Other classifications have been described, namely, the 
McMahon, Stewart-Way, and Hannover classifications, 
but these have no significant advantages in clinical prac-
tice [12–14].
In 2004, another definition was added to the biliary 
leak lexicology. In a retrospective review of 207 patients, 
Sandha et al. [2] proposed a two-category system for 
grading bile leak severity, i.e., low-grade (LG, i.e., a leak 
identified only after opacification of the intrahepatic bili-
ary duct) and high-grade (HG, i.e., a leak observed fluo-
roscopically before intrahepatic opacification. In their 
original report, the authors associated HG leaks with the 
need for more aggressive therapy (a combination of bili-
ary sphincterotomy and the placement of a transpapillary 
biliary stent) or worse outcomes (specifically, the need for 
placement of > 1 stent or even surgery).
Here, we will also refer to biliary leaks as LG or HG, 
and as simple or complex if they are associated with oth-
er injuries, namely, biliary strictures [2].
A B
C D
>2 cm
E1 E2
E3
E4
E5
<2 cm
Fig. 1. Strasberg classification of biliary injuries. Type A: bile leak 
from a cystic duct stump or Luschka’s duct leaks. Type B: occluded 
right posterior sectorial duct. Type C: bile leak from divided right 
posterior sectorial duct. Type D: bile leak from the main bile duct 
involving < 50% of its circumference. Type E1: transected main bile 
duct with a stricture of > 2 cm from the hilum. Type E2: stricture 
located < 2 cm from the hilum. Type E3: stricture of the hilum with 
right and left ducts in communication. Type E4: stricture separat-
ing the right and left ducts. Type E5: stricture of the main bile duct 
plus a stricture of the right posterior sectorial duct.
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Endoscopic Management of Biliary Leaks
ERCP has emerged as the primary treatment for biliary 
leaks. Binmoeller et al. [15], in 1991, first reported the en-
doscopic management of postoperative biliary leaks. In 
their original report, endoscopic treatment was techni-
cally successful in 95% of cases and resulted in biliary leak 
healing in 82%. Not surprisingly, they found that cystic 
stump leaks had a better prognosis for healing than com-
mon bile duct or hepatic duct leaks. Since then, and for a 
period of 30 years, published data have suggested a suc-
cess rate of ≥90% for leak closure (Table 1), currently ren-
dering ERCP the first-line treatment for biliary leaks [1–
5, 11, 16–18]. Several methods of endotherapy have been 
reported, and there is clearly conflict regarding the clini-
cal success of sphincterotomy, stenting, or a combination 
of the two. Other conflicting issues are: (a) small- versus 
large-diameter stents, (b) appropriate endotherapy for 
HG versus LG leaks, and (c) how to treat refractory biliary 
leaks. Finally, controversy about the timing of endother-
apy and stent retrieval remains. All of these issues are 
highlighted in this review.
Timing of Endoscopic Intervention
There is some controversy about the timing of endo-
scopic intervention. From the theoretical point of view, 
late treatment of biliary leaks can lead to serious adverse 
events and a higher mortality rate. However, there is no 
consensus about the appropriate timing of endotherapy 
for biliary leaks, and different centers recommend differ-
ent time points for performing ERCP. Some centers con-
sider biliary leakage to be an emergency whereas others 
treat it as a nonemergent procedure [16, 17].
The first study designed to investigate the relationship 
between the timing of endotherapy for a bile leak and the 
clinical outcomes was performed by Adler et al. [16] in 
2017. It was a multicenter, retrospective study including 
518 patients from 2 academic medical centers who under-
went ERCP following a biliary leak (70% postcholecystec-
tomy). The timing of ERCP was as follows: within the first 
24 h, on day 2 or 3, or after 3 days. There was no signifi-
cant difference in the rate of adverse events after the 
ERCP based on this timing. However, the 90-day mortal-
ity rate was lower in the group who underwent ERCP on 
day 2 or 3 than in those admitted for endotherapy within 
1 day or after 3 days, but this difference was not statisti-
cally significant.
In 2019, Abbas et al. [4] published a retrospective, na-
tionwide, inpatient analysis of 1,028 patients who under-
went ERCP for a bile leak. As in Adler et al. [16], ERCP 
was classified as an emergency, urgent, and expectant if it 
was performed within 1 day, after 2 or 3 days, or after 3 
days after the biliary leak occurred, respectively. The ratze 
of post-ERCP adverse events (defined as requiring pres-
sor infusion, endotracheal intubation, invasive monitor-
ing, or hemodialysis) were 11, 10, and 9% for emergency, 
urgent, and expectant ERCP, respectively, with no statis-
tically significant differences. However, also similar to 
Table 1. Studies reporting endoscopic management of biliary leaks
First author
[ref.]
Year Type Patients, 
n
ES, 
n
PS, 
n
ES + PS, 
n
Type of 
leak
Rate of clinical
success
Rate of ERCP
adverse events
Binmoeller [15] 1991 retrospective 77 n.a. n.a. n.a. n.a. 82% n.a.
Sandha [2] 2004 retrospective 207 81 126 LG + HG approx. 90% 1.5%
Kaffes [23] 2005 retrospective 89 18 40 31 n.a. approx. 93% 4%
Mavrogiannis [20] 2006 prospective 52 24 28 n.a. 100% 4.16%
de Reuver [11] 2007 retrospective 93 93 n.a. approx. 95% 13.8%
Katsinelos [25] 2008 prospective 63 63 n.a. 95% 12.7%
Canena [28] 2015 retrospective,
multicenter
178 178 LG + HG 91% 0%
Adler [16] 2017 retrospective,
multicenter
518 381 137 n.a. approx. 90% approx. 20%
Rainio [19] 2018 retrospective 71 50 21 n.a. 90% n.a.
Abbas [4] 2019 retrospective 1,028 247 247 534 n.a. approx. 95% 10%
Haidar [22] 2020 retrospective 96 11 9 76 LG + HG 90% 5%
ES, endoscopic sphincterotomy; PS, plastic stent; ERCP, endoscopic retrograde cholangiopancreatography; LG, low-grade; HG, high-
grade; n.a., not available.
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Adler et al. [16], they showed an in-hospital mortality 
with a U-shaped trend of 5, 0, and 2% for emergency, ur-
gent, and expectant ERCP, respectively (p < 0.001). The 
authors suggested that this finding may have resulted 
from a severity bias, i.e., that patients with greater initial 
clinical severity were more likely to undergo emergency 
ERCP or a late procedure until clinical stabilization. Ob-
viously, the clinically stable patients (with a theoretical 
better prognosis) received a planned ERCP within 2 or 3 
days. Both studies concluded that the timing of ERCP was 
not a significant predictor of post-ERCP adverse events, 
suggesting that ERCP can usually be performed in an 
elective rather than an urgent manner.
In the face of the dedicated available literature, offer-
ing a clear recommendation is not possible. However, and 
according to existing evidence, interventions for biliary 
leaks should not be delayed for longer than 3 or 4 days, 
especially if there is no evidence of reduction in the daily 
volume of a percutaneous drain output or if there is a 
clinical worsening scenario. Furthermore, there is also no 
clear indication for urgent intervention, except in cases 
where a large leak is documented or inferred by high vol-
ume drainage. Therefore, the suggestion emerging from 
the literature is that endoscopic intervention should take 
place on day 2 or 3 after a persisting biliary leak is diag-
nosed, although this is not a strong recommendation and 
the evidence is weak.
Sphincterotomy, Stenting, and Combination Therapy
Data from different studies have been used for com-
parison. In a trial from Turkey, 27 patients with a bile leak 
were randomized into 2 groups (sphincterotomy alone or 
stenting with or without sphincterotomy). They were al-
located into subgroups according to the diameter of the 
common bile duct. The authors observed a leak closure 
rate of 84.6% in the sphincterotomy group versus 100% 
in the stenting group [18]. However, Rainio et al. [19] ret-
rospectively analyzed 71 patients with a biliary leak who 
underwent sphincterotomy alone or sphincterotomy and 
stenting and found no significant difference in the pri-
mary healing rate between the sphincterotomy group and 
the sphincterotomy-plus-stenting group (90 vs. 90.4%). 
Mavrogiannis et al. [20] randomized 52 patients into 2 
groups. The first group included 24 patients treated with 
a 7-Fr biliary stent alone, and the second group had 28 
patients admitted for sphincterotomy followed by the in-
sertion of a 10-Fr stent. The researchers observed a leak-
closure rate of 100% in both groups, concluding that a 
small stent is as effective and safe as sphincterotomy and 
a large-bore stent. In a study from India, 72 patients were 
treated with sphincterotomy followed by nasobiliary 
drainage, plastic-stent placement, or nasobiliary drainage 
alone without sphincterotomy, and the success rate was 
100% in all groups [21]. Recently, Haidar et al. [22] re-
viewed 100 cases of biliary leaks (14% were HG) treated 
with stent insertion alone, sphincterotomy alone, or com-
bination therapy. In the subgroup analysis, the success 
rate of procedures with stent insertion (with or without 
sphincterotomy) was significantly higher than that of 
procedures without stent insertion (95.3 vs. 72.7%, p < 
0.05). The failure rate of sphincterotomy-alone proce-
dures (3/11, 27%) was significantly higher than that of 
procedures with stent insertion (4/85, 5%; p < 0.05). Kaf-
fes et al. [23] analyzed 100 patients with a biliary leak who 
were treated with sphincterotomy alone, stenting alone, 
sphincterotomy, or balloon sphincteroplasty plus stent-
ing. Endotherapy was unsuccessful in 7 patients (6 in the 
sphincterotomy-alone group; p = 0.001). Sandha et al. [2] 
conducted a retrospective review of 207 patients, and 
found that HG were better managed with a combination 
of stents and sphincterotomy, suggesting that this ap-
proach has the highest potential to seal a leak, particu-
larly in cases with more complex or problematic leaks. 
Furthermore, they found 7 failures in patients treated 
with sphincterotomy alone, and these required stenting 
for leak closure. Three recent studies have supplied more 
data. Vlaemynck et al. [24] conducted a systematic review 
with a meta-analysis using 11 studies. Network meta-
analysis was performed to compare sphincterotomy alone 
versus stenting alone versus combination treatment. 
Stenting was further stratified into leak-bridging and 
short-stenting. In their conclusion, the authors recom-
mend sphincterotomy with stenting if the biliary leak can 
be bridged. If not, stenting alone with a short stent may 
be preferred to avoid sphincterotomy-related complica-
tions. Abbas et al. [4] conducted a nationwide review of 
1,028 patients and observed that combination or stent 
monotherapy had lower failure rates than sphincteroto-
my monotherapy [4].
There are no definitive guidelines focusing on the en-
doscopic management of biliary leaks. From the litera-
ture, the idea emerges that stenting with or without 
sphincterotomy has better outcomes than sphincteroto-
my alone, and that, eventually, patients with a large prob-
ability of reintervention or complex/HG leaks will benefit 
from combination therapy.
Small-Diameter versus Large-Diameter Stents
Whereas stenting with or without sphincterotomy 
seems to be a key factor in the reduction of biliary system 
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pressure after the diagnosis of a biliary leak, the optimal 
size of the stent introduced during endotherapy is still a 
matter of debate. Diameters < 10 Fr was considered to be 
small and ≥10 Fr was considered a large diameter. There 
are only a few studies available for analysis in the litera-
ture. In the abovementioned study by Mavrogiannis et al. 
[20], there were no differences between patients treated 
with a 7-Fr plastic stent and those who underwent com-
bination therapy using a 10-Fr stent. In another study 
from Greece, after performing sphincterotomy in all cas-
es, patients were randomized to placement of either a 7-Fr 
or 10-Fr straight plastic stent for 4 weeks [25]; at the end 
of endotherapy, the success rate was similar in the 2 
groups (93.54 vs. 96.87%, respectively). Other studies, al-
though not designed to investigate this issue, presented 
similar results [2, 26]. In the abovementioned systematic 
review with meta-analysis, after a pooled analysis of 8 
studies, the risk of failure after endotherapy was reported 
as the odds ratio (OR) [24]. The authors reported an OR 
of 0.47 (95% confidence interval [CI] 0.12–1.75) when 
comparing treatment with large-diameter (n = 136, suc-
cess rate 97.8%) and small-diameter (n = 195, success rate 
= 95.4%) stents.
Complex and Refractory Leaks
Whereas the most frequent and more simple leaks (Stras-
berg Type A or Amsterdam type A) are very successfully 
treated with biliary sphincterotomy, placement of plastic 
a b
c d
e
Fig. 2. Fluoroscopic images of endoscopic management of a refrac-
tory biliary leak using a fully covered self-expandable metallic stent 
(FCSEMS). a A high-grade (HG) biliary leak from cystic stump. 
b After endoscopic placement of a single plastic stent. c Persistence 
of a HG biliary leak after 5 days of plastic stenting. d Immediately 
after endoscopic placement of a FCSEMS with immediate reduc-
tion in the contrast flow through the leak. e Follow-up cholangi-
ography immediately after FCSEMS removal at week 4. No con-
trast media extravasation is seen.
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stents, or both [1–3, 6], the optimal approach for more com-
plex and refractory leaks has not been determined.
In 2006, Baron and Poterucha [6] first reported that 3 
complex biliary leaks were treated successfully by using 
covered, expandable metal stents. They stated that the 
stents could stay in place for an arbitrary time of < 3 
months and did not have to be placed above the site of the 
leak to be effective, and that the successful closure of the 
leak was due to the diversion of bile away from the leak 
through the large-diameter stent. Three years later, a 
group from the USA reported a case series of 13 patients 
with complex leaks who underwent placement of fully 
covered, self-expandable metal stents (FCSEMSs) [27]. 
Although the researchers reported a success rate of 100%, 
there were several complications, and the prolonged time 
of stenting was associated with most of the adverse events. 
However, a study from Portugal evaluated 17 patients 
with refractory biliary leaks who underwent placement of 
an FCSEMS for ≤30 days [3]. The authors observed a 
100% success rate without adverse events, suggesting that 
short-term stenting is efficacious and not associated with 
adverse events. Furthermore, in biliary ducts where the 
diameter at the site of the leak is < 10 mm, the FCSEMS 
directly covers the leak site, increasing the potential for 
sealing the leak. However, in patients with a refractory 
biliary leak, instead of using an FCSEMS, the endoscopist 
can place > 1 plastic stent which can theoretically manage 
the refractory bile leak at a lower cost. In a retrospective 
multicenter study, 178 patients with a biliary leak were 
treated with combination therapy (biliary sphincteroto-
my and placement of a 10-Fr plastic stent), which yielded 
a success rate of 91% [1]. The remaining 16 patients had 
a HG leak, and in this group, placement of multiple (≥3) 
large-bore (10 Fr) plastic stents resulted in clinical success 
in 10 patients (62.5%). The remaining 6 patients were 
successfully treated with placement of an FCSEMS, re-
sulting in leak closure in all cases. After this suggestion of 
a better performance of FCSEMSs, only 1 study compar-
ing the clinical success of FCSEMSs with the placement 
of multiple plastic stents (MPSs) became available [28]. 
After endotherapy, leak closure was accomplished in 13 
patients (65%) who received MPSs, and in 20 (100%) who 
received FCSEMSs (p = 0.004). Furthermore, in the suc-
cessful cases, the median time to leak closure was 11 days 
in the MPS group and 3.5 days in the FCSEMS group. The 
use of < 3 plastic stents (p = 0.024), a summed plastic stent 
Simple/
low-grade
Complex/
high-grade FCSEMS
Leak closure (~50%)
Leak closure (~100%)
Leak closure
(~100%)
Leak closure
(>90%)
Leak closure
(~100%)
ES + 10-Fr PS ES + 10-Fr PS
Persisting
leak
Persisting
leak
MPS
Persisting
leak FCSEMS
Biliary leak
Fig. 3. Treatment of biliary leaks, a step-up approach. ES, endoscopic sphincterotomy; PS, plastic stent; MPS, 
multiple plastic stent; FCSEMS, fully covered self-expandable metallic stent.
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diameter below 20 Fr (p = 0.006), and a HG biliary leak 
(p = 0.015) were shown to be significant predictors of 
treatment failure with MPSs.
Taken together, these studies suggest that leaks that per-
sist after combination therapy with sphincterotomy and a 
single plastic stent should be considered for treatment with 
an FCSEMS, especially in the face of a HG leak (Fig. 2).
Stent Removal
Several studies report the time for leak closure using 
plastic stents. Most authors recommend the removal of 
plastic stents 4–8 weeks before stent obstruction, and this 
procedure is usually safe and without adverse events [1, 
20, 25]. Ultimately, due to the rapid recovery of most pa-
tients, stents can be removed even earlier (i.e., before dis-
charge from the hospital). Complications from the use of 
FCSEMSs in benign conditions have been reported [1, 3, 
27]. These include stent migration, bile duct and duode-
nal ulceration, bile duct strictures, and de novo choledo-
cholithiasis, with long-term stenting further increasing 
the complication rate. The optimal duration for which an 
FCSEMS should remain in place for the management of 
bile leaks is a matter of debate [3, 6, 27]. Nevertheless, 
there is some evidence that when stents stay in place for 
3–4 weeks, leak closure and a low rate of adverse events 
can be achieved [1, 3, 28]. Stents can be safely removed by 
grasping with a snare or foreign-body forceps, and apply-
ing constant traction [1, 3, 28, 29].
Conclusions
Biliary sphincterotomy, in combination with the 
placement of a single plastic stent for short periods, is as-
sociated with leak closure in > 90% of patients with post-
cholecystectomy bile leaks. Whereas there is no strong 
evidence that 10-Fr plastic stents are better than smaller 
ones, we concede that a larger stent may prevent clogging 
and obstruction, thereby assuring patency for longer pe-
riods. This option may be indicated when the leak flow is 
higher.
Refractory biliary leaks and ab initio HG or complex 
leaks should be treated with the placement of large-cali-
ber MPSs (ideally, ≥3, summing to at least 20 Fr) or FC-
SEMSs, with an expected closure rate of > 90%. All types 
of treatment with MPSs for refractory biliary leaks that 
are not successful should cross over to an FCSEMS that 
should stay in place for no longer than 3 or 4 weeks.
There are very limited indications for surgical biliary 
duct repair or percutaneous biliary drainage after ERCP 
in patients with postsurgical biliary leaks. An algorithm 
for the endoscopic management of biliary leaks is pro-
posed in Figure 3.
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